Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-12-06 6:31:53 am | Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders | GlobeNewsWire |
| 2023-12-04 6:30:0 am | GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia | GlobeNewswire |
| 2023-11-06 6:30:0 am | GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting | GlobeNewswire |
| 2023-11-01 6:0:0 am | GT Biopharma Reports Third Quarter 2023 Financial Results | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information